PRESS RELEASE published on 11/25/2025 at 18:30, 10 months 3 days ago EQS-Adhoc: LR HEALTH & BEAUTY SE RECEIVES SUPPORTING VOTING INTENTIONS BY 69.57% OF THE ADJUSTED NOMINAL AMOUNT FOR TEMPORARY WAIVERS UNDER THE 2024/2028 BONDS LR Health & Beauty SE has received support from bondholders representing 69.57% of adjusted nominal amount for temporary waivers under the 2024/2028 bonds Bondholders LR Health & Beauty SE 2024/2028 Bonds Temporary Waivers Voting Intentions
BRIEF published on 11/14/2025 at 15:51, 10 months 14 days ago LR Health & Beauty SE Seeks Bondholder Approval on Covenant Breach LR Health & Beauty Voting Deadline Covenant Breach Bond Procedure 2024/2028 Bonds
BRIEF published on 11/14/2025 at 15:51, 10 months 14 days ago LR Health & Beauty SE sollicite l'approbation des obligataires suite à une violation de ses engagements. Date Limite De Vote Procédure De Cautionnement Violation De L'engagement LR Santé Et Beauté Obligations 2024/2028
PRESS RELEASE published on 11/14/2025 at 15:46, 10 months 14 days ago LR Health & Beauty SE initiates a Written Procedure under its outstanding 2024/2028 Bonds LR Health & Beauty SE initiates a Written Procedure among Bondholders to address an expected covenant breach regarding net debt to EBITDA ratio of 2024/2028 Bonds Bondholders Financial LR Health & Beauty Written Procedure Leverage Covenant
BRIEF published on 10/24/2025 at 18:55, 11 months 4 days ago LR Health & Beauty SE Reports Q3 2025 Business Development EBITDA Forecast Sales Decline LR Health & Beauty Q3 2025 Results Fragrance Portfolio
BRIEF published on 10/24/2025 at 18:55, 11 months 4 days ago LR Health & Beauty SE publie son développement commercial au troisième trimestre 2025 Baisse Des Ventes Prévisions D'EBITDA LR Santé & Beauté Résultats Du Troisième Trimestre 2025 Portefeuille De Parfums
PRESS RELEASE published on 10/24/2025 at 18:50, 11 months 4 days ago LR Health & Beauty SE reports on business development in the third quarter of 2025 LR Health & Beauty SE reports on business development in Q3 2025, with sales of EUR 66.0 million and EBITDA of EUR 2.9 million. Focus on fragrance segment, capital structure, and earnings guidance revision Sales EBITDA Business Development Fragrance LR Health & Beauty SE
BRIEF published on 10/20/2025 at 20:22, 11 months 8 days ago LR Health & Beauty SE Faces Financial Challenges Amid Leverage Covenant Breach Financial Restructuring LR Health & Beauty Interest Payment Deferral Bondholder Negotiations Leverage Covenant Breach
BRIEF published on 10/20/2025 at 20:22, 11 months 8 days ago LR Health & Beauty SE confrontée à des difficultés financières suite à une violation de la clause d'endettement Restructuration Financière LR Santé & Beauté Report Du Paiement Des Intérêts Négociations Avec Les Obligataires Violation De L'alliance De Levier
PRESS RELEASE published on 10/20/2025 at 20:17, 11 months 8 days ago EQS-Adhoc: LR Health & Beauty SE: BREACH OF LEVERAGE COVENANT / NO INTEREST PAYMENT / STANDSTILL NEGOTIATIONS WITH AN AD HOC GROUP OF BONDHOLDERS / APPOINTMENT OF A REPUTABLE FIRM TO SUPPORT ... LR Health & Beauty SE announces breach of leverage covenant, no interest payment, and standstill negotiations with bondholders. Firm appointed to support financial restructuring Bondholders LR Health & Beauty SE Financial Restructuring Leverage Covenant Standstill Negotiations
Published on 09/29/2026 at 06:45, 2 hours 15 minutes ago Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries
Published on 09/29/2026 at 04:36, 4 hours 24 minutes ago The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)
Published on 09/29/2026 at 02:30, 6 hours 30 minutes ago QNX and neueHCT Join Forces to Accelerate Global Intelligent Driving Deployment, Anchored by Major German Automaker Program Win
Published on 09/29/2026 at 00:00, 9 hours ago Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Published on 09/28/2026 at 23:00, 10 hours ago CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives
Published on 09/29/2026 at 08:30, 30 minutes ago 2G Energy AG again secures orders exceeding EUR 400 million in the third quarter
Published on 09/29/2026 at 08:10, 50 minutes ago Segway Powersports Brings Latin American and Canadian Media and Creators from Factory Floor to Real-World Terrain
Published on 09/29/2026 at 08:05, 55 minutes ago EPAM Ranks #1 for Satisfaction and Delivery in 2026 Swiss Whitelane Research Study
Published on 09/29/2026 at 08:05, 55 minutes ago One of Germany's Leading Veterinary Networks Chooses CoVet AI to Modernize Clinical Documentation
Published on 09/29/2026 at 08:00, 1 hour ago Photon Energy N.V. Commissioned EY-P as an Independent Business Review Provider
Published on 09/29/2026 at 08:45, 15 minutes ago Cegedim Santé réinvente l’accès à l’information médicale en déployant l’Assistant by Claude Bernard IA sur toutes ses solutions de médecine de ville
Published on 09/28/2026 at 17:54, 15 hours 5 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 15 hours 5 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:45, 15 hours 15 minutes ago Déclaration hebdomadaire de rachat d'actions